Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial
ILiAD Biotechnologies
Cheryl Keech; Vicki E Miller; Barbara Rizzardi; Christopher Hoyle; Melinda J Pryor; Jonathan Ferrand; Ken Solovay; Marcel Thalen; Stephanie Noviello; Peter Goldstein; Andrew Gorringe; Breeze Cavell; Qiushui He; Alex-Mikael Barkoff; Keith Rubin; Camille Locht